Document Detail

Sex differences in the enhanced responsiveness to acute angiotensin II in growth-restricted rats: role of fasudil, a Rho kinase inhibitor.
MedLine Citation:
PMID:  23344570     Owner:  NLM     Status:  MEDLINE    
This study tested the hypothesis that Rho kinase contributes to the enhanced pressor response to acute angiotensin II in intact male growth-restricted and gonadectomized female growth-restricted rats. Mean arterial pressure (MAP) and renal function were determined in conscious animals pretreated with enalapril (250 mg/l in drinking water) for 1 wk to block the endogenous renin-angiotensin system and normalize blood pressure (baseline). Blood pressure and renal hemodynamics did not differ at baseline. Acute Ang II (100 ng·kg(-1)·min(-1)) induced a greater increase in MAP and renal vascular resistance and enhanced reduction in glomerular filtration rate in intact male growth-restricted rats compared with intact male controls (P < 0.05). Cotreatment with the Rho kinase inhibitor fasudil (33 μg·kg(-1)·min(-1)) significantly attenuated these hemodynamic changes (P < 0.05), but it did not abolish the differential increase in blood pressure above baseline, suggesting that the impact of intrauterine growth restriction on blood pressure in intact male growth-restricted rats is independent of Rho kinase. Gonadectomy in conjunction with fasudil returned blood pressure back to baseline in male growth-restricted rats, and yet glomerular filtration rate remained significantly reduced (P < 0.05). Thus, these data suggest a role for enhanced renal sensitivity to acute Ang II in the developmental programming of hypertension in male growth-restricted rats. However, inhibition of Rho kinase had no effect on the basal or enhanced increase in blood pressure induced by acute Ang II in the gonadectomized female growth-restricted rat. Therefore, these studies suggest that Rho kinase inhibition exerts a sex-specific effect on blood pressure sensitivity to acute Ang II in growth-restricted rats.
Norma B Ojeda; Thomas P Royals; Barbara T Alexander
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2013-01-23
Journal Detail:
Title:  American journal of physiology. Renal physiology     Volume:  304     ISSN:  1522-1466     ISO Abbreviation:  Am. J. Physiol. Renal Physiol.     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-04-02     Completed Date:  2013-05-23     Revised Date:  2014-04-01    
Medline Journal Info:
Nlm Unique ID:  100901990     Medline TA:  Am J Physiol Renal Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  F900-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives*,  pharmacology
Angiotensin II / pharmacology*
Blood Pressure / drug effects*
Enalapril / pharmacology
Fetal Growth Retardation / physiopathology*
Glomerular Filtration Rate / drug effects
Hemodynamics / drug effects
Kidney / drug effects,  physiopathology
Placental Insufficiency / physiopathology
Prenatal Exposure Delayed Effects / physiopathology
Renal Circulation / drug effects
Renin-Angiotensin System / drug effects
Sex Characteristics
Vascular Resistance / drug effects
rho-Associated Kinases / antagonists & inhibitors,  physiology*
Grant Support
Reg. No./Substance:
103745-39-7/fasudil; 11128-99-7/Angiotensin II; 69PN84IO1A/Enalapril; 84477-87-2/1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; EC Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cremated human remains: is measurement of the lateral angle of the meatus acusticus internus a relia...
Next Document:  Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats.